Accord Bortezomib 3.5 (Bortezomib powder for solution for injection 3.5 mg/vial)

Manufacturer
INTAS PHARMACEUTICALS LIMITED
 
Content
Bortezomib
 
Indication
Multiple myeloma & mantle cell lymphoma (MCL) in patients who have received at least 1 prior therapy.
 
Instruction
Administer via IV
 
Drug interaction
Concurrent use of amiodarone, antivirals, isoniazid, nitrofurantoin, statins may increase the chance of peripheral neuropathy. Concurrent use of antihypertensives increases the chance of hypotension.